Gazit Globe Announces Date for Q1 2017 Results Conference Call

TEL AVIV, Israel, April 25, 2017 (GLOBE NEWSWIRE) -- Gazit-Globe (NYSE: GZT) (TSX: GZT) (TASE: GZT), invites you to participate at 10:00 am US EDT/ 5:00 pm Israel Time on Tuesday, May 23rd, 2017 in a live conference call with senior management to discuss the Company’s results for the first quarter ended March 31, 2017.

Gazit Globe’s financial statements and MD&A for the quarter will be released prior to the call, and will be available on the Company's website at: www.gazitglobe.com in the "Investor Relations" section and on the U.S. Securities and Exchange Commission's website at www.sec.gov/edgar.shtml as well as on the Canadian Securities Administrators’ website at www.sedar.com.

The conference call can be accessed by dialing: 

United States 1888 668 9141

Canada 1866 485 2399

United Kingdom   0800 917 5108

International / Israel +972 3 9180644

A presentation and replay of the call will be available on the company’s website, in the "Investor Relations" section.

Webcast link: http://www.veidan-stream.com/?con=Gazit_Globe_Q1_2017_Results_Conference_Call

About Gazit-Globe

Gazit-Globe is a global owner, developer and operator of high quality necessity-driven supermarket-anchored retail properties in urban markets. Gazit-Globe is listed on the New York Stock Exchange (NYSE: GZT), the Toronto Stock Exchange (TSX: GZT) and the Tel Aviv Stock Exchange (TASE: GZT) and is included in the TA-35 index in Israel. As of December 31, 2016, Gazit-Globe owns and operates 426 properties in 20 countries, with a gross leasable area of approximately 6.6 million square meters and a total value of approximately US$ 22 billion.

FOR ADDITIONAL INFORMATION

Investors Contact: [email protected], Media Contact: [email protected]

Gazit-Globe Headquarters, Tel-Aviv, Israel, Tel: +972 3 6948000 

You May Also Be Interested In

• Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
• Greenlane Holdings Inc. (GNLN) Receives Nasdaq Non-compliance Notice
• INmune Bio (INMB) Prices 986K Share Offering at $9.84/sh